(IYH) iShares U.S. Healthcare - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642877629 • Health
IYH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Equipment, Services
The iShares U.S. Healthcare ETF, traded on the NYSE ARCA under the ticker IYH, is designed to track the performance of the healthcare sector within the U.S. equity market. By investing at least 80% of its assets in the component securities of its underlying index, the fund provides exposure to a broad range of healthcare companies, including pharmaceuticals, biotechnology, and medical devices. This approach allows investors to gain diversified exposure to the healthcare sector, which can be beneficial for those looking to capitalize on the growth potential of this industry.
As a non-diversified fund, the iShares U.S. Healthcare ETF may concentrate its investments in a smaller number of securities, which can result in higher volatility compared to more diversified funds. However, this focus on the healthcare sector can also provide more targeted exposure to the industry's trends and opportunities. The fund's underlying index is designed to measure the performance of the healthcare sector of the U.S. equity market, providing a benchmark for the fund's performance. With its listing on the NYSE ARCA and domicile in the United States, the fund is subject to U.S. regulatory requirements and oversight.
In terms of its structure, the iShares U.S. Healthcare ETF is an exchange-traded fund (ETF), which means it trades on an exchange like a stock and can be bought and sold throughout the day. This provides investors with flexibility and liquidity, as they can easily enter or exit positions in the fund. The fund's ISIN, US4642877629, is a unique identifier used to facilitate trading and settlement. As part of the iShares family of ETFs, the fund is supported by a well-established brand with a reputation for providing a range of investment solutions. More information about the fund and its sponsor can be found at http://www.ishares.com.
Additional Sources for IYH ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IYH ETF Overview
Market Cap in USD | 3,113m |
Category | Health |
TER | 0.40% |
IPO / Inception | 2000-06-12 |
IYH ETF Ratings
Growth 5y | 58.4% |
Fundamental | - |
Dividend | 49.6% |
Rel. Strength Industry | -86.2 |
Analysts | - |
Fair Price Momentum | 55.79 USD |
Fair Price DCF | - |
IYH Dividends
Dividend Yield 12m | 1.21% |
Yield on Cost 5y | 1.79% |
Annual Growth 5y | 4.91% |
Payout Consistency | 95.1% |
IYH Growth Ratios
Growth Correlation 3m | -80.1% |
Growth Correlation 12m | 32.6% |
Growth Correlation 5y | 85.3% |
CAGR 5y | 8.25% |
CAGR/Mean DD 5y | 1.69 |
Sharpe Ratio 12m | 0.00 |
Alpha | -17.57 |
Beta | 0.76 |
Volatility | 13.36% |
Current Volume | 317.6k |
Average Volume 20d | 332.8k |
As of January 23, 2025, the stock is trading at USD 60.22 with a total of 317,600 shares traded.
Over the past week, the price has changed by +1.23%, over one month by +2.40%, over three months by -5.36% and over the past year by +3.75%.
Partly, yes. Based on ValueRay Analyses, iShares U.S. Healthcare (NYSE ARCA:IYH) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.43 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IYH as of January 2025 is 55.79. This means that IYH is currently overvalued and has a potential downside of -7.36%.
iShares U.S. Healthcare has no consensus analysts rating.
According to ValueRays Forecast Model, IYH iShares U.S. Healthcare will be worth about 61.6 in January 2026. The stock is currently trading at 60.22. This means that the stock has a potential upside of +2.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 61.6 | 2.2% |